Menu Search
Equities

Pfizer Inc

PFE:BLG

Pfizer Inc

Actions
  • Price (--)--
  • Today's Change--
  • Shares traded--
  • 1 Year change--
  • Beta--
--
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Pfizer Inc's revenues fell -41.70% from 100.33bn to 58.50bn. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from 31.37bn to 2.12bn, a -93.25% decrease.
Gross margin70.82%
Net profit margin7.16%
Operating margin5.07%
Return on assets1.98%
Return on equity4.52%
Return on investment2.39%
More ▼

Cash flow in USDView more

In 2023, Pfizer Inc increased its cash reserves by 523.29%, or 2.45bn. Cash Flow from Financing totalled 26.07bn or 44.56% of revenues. In addition the company generated 8.70bn in cash from operations while cash used for investing totalled 32.28bn.
Cash flow per share1.97
Price/Cash flow per share12.72
Book value per share16.29
Tangible book value per share-6.40
More ▼

Balance sheet in USDView more

Pfizer Inc has a Debt to Total Capital ratio of 42.25%, a lower figure than the previous year's 62.98%.
Current ratio1.00
Quick ratio0.729
Total debt/total equity0.7336
Total debt/total capital0.4225
More ▼

Growth rates in USD

SmartText is unavailable
Div yield(5 year avg)3.64%
Div growth rate (5 year)3.82%
Payout ratio (TTM)221.03%
EPS growth(5 years)-7.10
EPS (TTM) vs
TTM 1 year ago		-59.14
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.